Octave Bioscience Secures $14 Million Series A Financing Round MENLO PARK, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Octave Bioscience, the developer of a fully integrated care management solution delivering powerful insights for patients with neurodegenerative...